Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Bioprocessing - Upstream & Downstream

Discovery & Development Bioprocessing - Upstream & Downstream

A New Era for Cell Culture Media

How a better understanding of raw materials has increased the potential for biopharmaceutical companies to understand their process variability.

Manufacture Bioprocessing - Single Use Systems

What's Next

Exploring the Future of Bioprocessing Together.

Manufacture Bioprocessing - Upstream & Downstream

Mastering Continuous Biomanufacturing-MS

| Rickey Lu

Interviewing Rickey Lu, Director of Manufacturing Technology Innovation, at AstraZeneca.

Manufacture Bioprocessing - Upstream & Downstream

New Horizons-MS

| Gorazd Hribar

A consortium funded by Horizon 2020 aims to bring biopharma manufacturing into the 21st century.

Manufacture Bioprocessing - Upstream & Downstream

Perfecting Perfusion-MS

| Delia Lyons

MilliporeSigma has developed a CHO cell perfusion medium specifically designed for untensified perfusion processes.

Manufacture Bioprocessing - Upstream & Downstream

Putting Single-Pass Tangential Flow Filtration into Place-MS

| Herb Lutz

Industry already has the technologies it needs for next generation bioprocessing - it just needs to deploy them effectively.

Manufacture Bioprocessing - Upstream & Downstream

The Connected Process-MS

| Michael Phillips, Janmeet Anant

Connecting processed is about running unit operations as a single unit, but how exactly is this achieved?

Manufacture Bioprocessing - Upstream & Downstream

Facing the future-MS

| Jonathan Souquet, Merrilee Whitney

A supplier and a manufacturer share their views on why next generation bioprocessing is so important.

Manufacture Bioprocessing - Upstream & Downstream

Welcome to the Next Generation of Bioprocessing-MS

| Sponsored by MilliporeSigma

What is next generation bioprocessing? And how should it be implemented successfully?

Manufacture Bioprocessing - Upstream & Downstream

The Problem with Poloxamers-MS

| Sponsored by MilliporeSigma

Poloxamer 188 has become an essential component of cell culture media, but lot-to-lot variability has been a problem for many biopharma manufacturers.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine